Our Vision
ennov1 envisions a world where every person suffering from cancer is able to use their personal genomic and health data to eliminate their disease and achieve optimal health and wellness.
Our Vision
ennov1 envisions a world where every person suffering from cancer is able to use their personal genomic and health data to eliminate their disease and achieve optimal health and wellness.
Our Story
Our company is owned and controlled by cancer patients, including our late founder Stephen Aldrich. Stephen was a Stage 4 adenocarcinoma of the esophagus patient who was able to use his full genomic sequence data to make optimal treatment decisions regarding his cancer.
He obtained access to personalized immunotherapy options – including a personalized neoantigen vaccine, which led to his surviving and thriving for three full years beyond expectations. Our job is to enable patients to use their data as Stephen used his — to make optimal treatment decisions and directly access advanced therapy options.
Owned and Run for People with Cancer
ennov1’s founding members are also its first customers. We are late-stage cancer patients with the goal of using our fundamental health data to eliminate our cancers and to achieve optimum health and wellness. We envision a world where all people dealing with incurable cancers are able to leverage their health data to quickly identify the best available, personalized treatment options.
We are committed to
Guiding you to the genomic data you need to gather and store
Connecting you with expert providers to identify the best available and personalized treatment options for your genetically unique cancer
Providing guidance on gathering, storing, and interpreting data, and monitoring the status of your disease
Accelerating the adoption of the most advanced and sophisticated cancer treatments
Founding Members
Founding Members are all cancer patients, as well as initial customers and investors in ennov1.
Our service offering is being designed around their needs and with their input.
